USA - NASDAQ:EDSA - CA27966L3065 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to EDSA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating | 
|---|---|---|---|
| 2025-11-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy | 
| 2025-03-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy | 
| 2024-08-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy | 
| 2024-06-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy | 
| 2024-02-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy | 
| 2023-11-29 | HC Wainwright & Co. | Maintains | Buy -> Buy | 
| 2023-11-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy | 
| 2023-10-12 | Brookline Capital | Maintains | Buy -> Buy | 
| 2023-08-15 | HC Wainwright & Co. | Maintains | Buy -> Buy | 
| 2023-05-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy | 
| 2023-03-15 | HC Wainwright & Co. | Reiterate | Buy | 
| 2023-02-14 | HC Wainwright & Co. | Reiterate | Buy | 
| 2021-12-20 | HC Wainwright & Co. | Initiate | Buy | 
8 analysts have analysed EDSA and the average price target is 10.54 USD. This implies a price increase of 505.75% is expected in the next year compared to the current price of 1.74.
The consensus rating for EDESA BIOTECH INC (EDSA) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering EDESA BIOTECH INC (EDSA) is 8.